Castañón, Eduardo <br/><br/>
Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis.  [electronic resource] 

 -  Journal of translational medicine  Aug 2015 
 - 257 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1479-5876 
<br/><br/><label>Standard No.: </label>10.1186/s12967-015-0622-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>ErbB Receptors--genetics<br/>Humans<br/>Liver Neoplasms--secondary<br/>Lung Neoplasms--drug therapy<br/>Mutation--genetics<br/>Neoplasm Staging<br/>Prognosis<br/>Survival Analysis